These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A short peptide fragment of the vascular endothelial growth factor as a novel ligand for bevacizumab purification. Barredo GR; Giudicessi SL; Martínez Ceron MC; Saavedra SL; Rodriguez S; Filgueira Risso L; Erra-Balsells R; Mahler G; Albericio F; Cascone O; Camperi SA Protein Expr Purif; 2020 Jan; 165():105500. PubMed ID: 31542564 [TBL] [Abstract][Full Text] [Related]
3. Peptide Affinity Chromatography Applied to Therapeutic Antibodies Purification. Barredo-Vacchelli GR; Giudicessi SL; Martínez-Ceron MC; Cascone O; Camperi SA Int J Pept Res Ther; 2021; 27(4):2905-2921. PubMed ID: 34690622 [TBL] [Abstract][Full Text] [Related]
4. A new tetrapeptide biomimetic chromatographic resin for antibody separation with high adsorption capacity and selectivity. Fang YM; Chen SG; Lin DQ; Yao SJ J Chromatogr A; 2019 Oct; 1604():460474. PubMed ID: 31493850 [TBL] [Abstract][Full Text] [Related]
5. Recombinant human follicle stimulating hormone purification by a short peptide affinity chromatography. Gurevich Messina JM; Giudicessi SL; Martínez Ceron MC; Urtasun N; Forno G; Mauro L; Cascone O; Camperi SA J Pept Sci; 2018 Nov; 24(11):e3128. PubMed ID: 30288867 [TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies targeting vascular endothelial growth factor: current status and future challenges in cancer therapy. Hsu JY; Wakelee HA BioDrugs; 2009; 23(5):289-304. PubMed ID: 19754219 [TBL] [Abstract][Full Text] [Related]
7. Genetic delivery of the murine equivalent of bevacizumab (avastin), an anti-vascular endothelial growth factor monoclonal antibody, to suppress growth of human tumors in immunodeficient mice. Watanabe M; Boyer JL; Hackett NR; Qiu J; Crystal RG Hum Gene Ther; 2008 Mar; 19(3):300-10. PubMed ID: 18324912 [TBL] [Abstract][Full Text] [Related]
8. Innovative next-generation monoclonal antibody purification using activated carbon: A challenge for flow-through and column-free processes. Ishihara T; Miyahara M; Yamada T; Yamamoto K J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jul; 1121():72-81. PubMed ID: 31128526 [TBL] [Abstract][Full Text] [Related]
9. Development and validation of an affinity chromatography step using a peptide ligand for cGMP production of factor VIII. Kelley BD; Tannatt M; Magnusson R; Hagelberg S; Booth J Biotechnol Bioeng; 2004 Aug; 87(3):400-12. PubMed ID: 15281114 [TBL] [Abstract][Full Text] [Related]
10. Novel peptide ligand with high binding capacity for antibody purification. Lund LN; Gustavsson PE; Michael R; Lindgren J; Nørskov-Lauritsen L; Lund M; Houen G; Staby A; St Hilaire PM J Chromatogr A; 2012 Feb; 1225():158-67. PubMed ID: 22251884 [TBL] [Abstract][Full Text] [Related]
11. Purification of monoclonal antibodies by epitope and mimotope affinity chromatography. Murray A; Sekowski M; Spencer DI; Denton G; Price MR J Chromatogr A; 1997 Oct; 782(1):49-54. PubMed ID: 9368405 [TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody purification using activated carbon as a replacement for Protein A affinity chromatography. Ishihara T; Miyahara M; Yamamoto K J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Dec; 1102-1103():1-7. PubMed ID: 30366207 [TBL] [Abstract][Full Text] [Related]
13. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors. Haskell-Luevano C; Nikiforovich G; Sharma SD; Yang YK; Dickinson C; Hruby VJ; Gantz I J Med Chem; 1997 May; 40(11):1738-48. PubMed ID: 9171884 [TBL] [Abstract][Full Text] [Related]
14. Efficient Production of a Bioactive Bevacizumab Monoclonal Antibody Using the 2A Self-cleavage Peptide in Transgenic Rice Callus. Chen L; Yang X; Luo D; Yu W Front Plant Sci; 2016; 7():1156. PubMed ID: 27555853 [TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody purification by affinity chromatography with ligands derived from the screening of peptide combinatory libraries. Camperi SA; Iannucci NB; Albanesi GJ; Oggero Eberhardt M; Etcheverrigaray M; Messeguer A; Albericio F; Cascone O Biotechnol Lett; 2003 Sep; 25(18):1545-8. PubMed ID: 14571980 [TBL] [Abstract][Full Text] [Related]
16. Integration of novel agents in the treatment of colorectal cancer. Iqbal S; Lenz HJ Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S32-9. PubMed ID: 15309512 [TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic. Ranieri G; Patruno R; Ruggieri E; Montemurro S; Valerio P; Ribatti D Curr Med Chem; 2006; 13(16):1845-57. PubMed ID: 16842197 [TBL] [Abstract][Full Text] [Related]
18. Purification of human erythropoietin by affinity chromatography using cyclic peptide ligands. Kish WS; Roach MK; Sachi H; Naik AD; Menegatti S; Carbonell RG J Chromatogr B Analyt Technol Biomed Life Sci; 2018 May; 1085():1-12. PubMed ID: 29625371 [TBL] [Abstract][Full Text] [Related]
19. Pilot-scale process for magnetic bead purification of antibodies directly from non-clarified CHO cell culture. Brechmann NA; Eriksson PO; Eriksson K; Oscarsson S; Buijs J; Shokri A; Hjälm G; Chotteau V Biotechnol Prog; 2019 May; 35(3):e2775. PubMed ID: 30629859 [TBL] [Abstract][Full Text] [Related]
20. Review on biomimetic affinity chromatography with short peptide ligands and its application to protein purification. Fang YM; Lin DQ; Yao SJ J Chromatogr A; 2018 Oct; 1571():1-15. PubMed ID: 30097342 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]